Immucell Corp

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.05

-0.42 (-4.96%)

As of May 16, 2:18 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -47.0% upside

Low Target $3.74

Average Target $4.27

High Target $6.64

Current Price $8.05

Current
$8.05

Target
$4.27

$3.74 $4.27 avg $6.64

Scenario Analysis

Bear Case

$3.74

-53.5%

Low target

Base Case

$4.27

-47.0%

Avg target

Bull Case

$6.64

+-17.5%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$9.08

-11.3% from high

52-Week Low

$4.52

+78.1% from low

Target vs 52W High

$4.27

-53.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%